SCHEMBL17495221

SCHEMBL17495221

OCC=Cc1ccc(Cl)cc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
GPR183 P32249 1/20 0.38
NFE2L2 Q16236 4/20 0.37
ALDH1A1 P00352 2/20 0.35
CYP3A4 P08684 1/20 0.35
RECQL P46063 1/20 0.35
MIF P14174 1/20 0.35
LMNA P02545 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
PTGS1 P23219 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10254846 0.81 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL14416457 0.81 HDAC3 (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL3605644 0.81 TDP1 (0.50) ALDH1A1LMNATDP1KDM4EGAA
SCHEMBL5265029 0.81 NFE2L2 (0.55) NFE2L2ALDH1A1CYP3A4RECQLMIF
SCHEMBL3605648 0.81 TDP1 (0.50) ALDH1A1LMNATDP1KDM4EGAA
SCHEMBL5841570 0.79 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5841566 0.79 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL22038315 0.78 NFE2L2 (0.50) NFE2L2ALDH1A1CYP3A4RECQLMIF
SCHEMBL22122733 0.78 NPC1 (0.37) ALDH1A1CYP3A4RECQLLMNATDP1
SCHEMBL22145213 0.78 NPC1 (0.37) ALDH1A1CYP3A4RECQLLMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177285-A1 [5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2017-06-14 EP disclosed
WO-2016022446-A1 [5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2016-02-11 WO disclosed